Thibert Jean-Baptiste, Polomeni Alice, Yakoub-Agha Ibrahim, Bordessoule Dominique
EFS Bretagne, unité de thérapie cellulaire, rue Pierre-Jean-Gineste, 35016 Rennes, France.
Assistance publique-Hôpitaux de Paris, hôpital Saint-Antoine, service d'hématologie clinique et thérapie cellulaire, 184, rue du Faubourg-St-Antoine, 75012 Paris, France.
Bull Cancer. 2016 Nov;103(11S):S207-S212. doi: 10.1016/j.bulcan.2016.09.010. Epub 2016 Nov 14.
Informed consent is not restricted to clinical research and must be applied to high-risk care such as hematopoietic stem cell transplantation. If standardized informed consent might improve inequalities in medical practices between different transplantation centers, it is strongly recommended that it be adapted with an honest dialogue between physicians and patients and physicians and donors. In an attempt to harmonize clinical practices among French hematopoietic stem cell transplantation centers, the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) held its sixth annual workshop series in September 2015 in Lille. This event brought together practitioners from across the country. The purpose of this paper is to highlight the French law concerning patients' rights and ethical practices for an informed consent process to be applied to care or research.
知情同意并不局限于临床研究，还必须应用于造血干细胞移植等高风险治疗。如果标准化的知情同意可能改善不同移植中心医疗实践中的不平等现象，强烈建议通过医生与患者以及医生与捐赠者之间的坦诚对话来进行调整。为了协调法国各造血干细胞移植中心的临床实践，法语国家骨髓移植与细胞治疗协会（SFGM-TC）于2015年9月在里尔举办了第六届年度研讨会系列活动。该活动汇聚了来自全国各地的从业者。本文的目的是强调法国关于患者权利以及适用于治疗或研究的知情同意过程的道德规范的法律。
